5-hydroxy-2'-deoxycytidine: a major oxidation product of 2'-deoxycytidine
ID Source | ID |
---|---|
PubMed CID | 477413 |
CHEMBL ID | 217849 |
SCHEMBL ID | 529289 |
MeSH ID | M0200081 |
Synonym |
---|
5-ohdc |
5-hydroxydeoxycytidine' |
4-amino-5-hydroxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one |
5-hydroxydeoxycytidine |
52278-77-0 |
5-oh-dc |
cytidine, 2'-deoxy-5-hydroxy- |
5-hydroxy-2'-deoxycytidine |
2'-deoxy-5-hydroxycytidine |
CHEMBL217849 |
4-amino-5-hydroxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
unii-6jhe7fc4bx |
oh-5-dc |
ccris 8238 |
6jhe7fc4bx , |
cytidine,2'-deoxy-5-hydroxy- |
BRD-K28271329-001-01-2 |
SCHEMBL529289 |
CKZJTNZSBMVFSU-UBKIQSJTSA-N |
4-amino-5-hydroxy-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1h)-one |
mfcd01937860 |
1-(2-deoxypentofuranosyl)-4-imino-1,4-dihydropyrimidine-2,5-diol |
DTXSID00966652 |
Q27265006 |
4-amino-5-hydroxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
2'-deoxy-5-hydroxy-cytidine |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID273213 | Antiviral activity against coxsackievirus B3 in HeLa S3 cells assessed as reduction in viral titer | 2006 | Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21 | Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. |
AID273212 | Antiviral activity against poliovirus in HeLa S3 cells assessed as reduction in viral titer | 2006 | Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21 | Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. |
AID273211 | Viability of human HeLa S3 cells | 2006 | Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21 | Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (38.10) | 18.2507 |
2000's | 9 (42.86) | 29.6817 |
2010's | 4 (19.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |